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ISCHEMIA-REPERFUSION Pretreatment with pentoxifylline attenuates lung injury induced by
intestinal ischemia/reperfusion in rats 1 Pré-tratamento com pentoxifilina atenua a lesão pulmonar induzida por isquemia/reperfusão intestinal em ratos 
Carlos Eduardo Marqui
Introduction
Regardless the cause, an intestinal ischemia insult is a serious and growing clinical problem, with an unacceptable mortality rate over 60% 1 
.
Intestinal ischemia and reperfusion (I/R) leads to an acute local inflammatory response, resulting in increased microvascular permeability. Intestinal I/R is a common medical event associated with both clinical and experimental distant organ injury. In particular, the lung tissue appears to be susceptible to injury resulting from systemic oxidative stress and inflammatory mediators activation. Despite decades of research in this area, I/R injury remains a clinically challenging problem [2] [3] [4] [5] [6] [7] and particularly susceptible to the damaging effects of increased neutrophil activation following intestinal I/R
8
. Consequently, many cases of intestinal I/R progress into shock, multiple organ failure, and death 9, 10 .
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) is a consequence of host response to a variety of direct or indirect stimuli leading to pulmonary inflammation.
Many of the clinical conditions associated with the development of acute respiratory failure include periods of ischemia [11] [12] [13] . Pentoxifylline (PTX), a methylxanthine derivative known for many years for its haemorheological properties, has proven to be a potent inhibitor of tumor necrosis factor (TNF) production 14 . It has been suggested that PTX can enhance the chemotactic response of neutrophils, but may inhibit phagocytosis and the superoxide production by neutrophils and monocytes 15 . It has also been shown that this drug has beneficial effects in patients with lung ischemia/reperfusion injury 16 . The potential local effects are important for acute lung injury manifestation by inflammatory mediators that are blood-and lymph-borne x,y,z
, and oxygen-free radical activations 17, 18 .
Based on these literature data, herein we put forward the hypothesis that the pre-treatment with PTX may reduce lung injury in rats submitted to intestinal ischemia/reperfusion. For this purpose we used an animal model of intestinal I/R in which a superior mesenteric artery occlusion-reperfusion simulates the I/R injury that may occur in clinical situations, and investigated the effects of PTX on the systemic (pulmonary) repercussions of this insult.
Methods
Surgical procedure and experimental design
All animal procedures were approved by the Institutional
Research Committee at Federal University of Sao Paulo (1551/09).
It was designed as an experimental, randomized, controlled study with blind assessment to the outcome.
Twenty-eight adult male Wistar rats (n=7 for every group; body weights were 270 to 300 g) were fasted overnight with free access to water. Anesthesia was induced by a single 
Determination of lipid derived oxidation products
The thiobarbituric acid reactive substancemalondiadehyde (TBARS-MDA) content of lung tissue was determined using the method described by Ohkawa et al. 28 .
Myeloperoxidase (MPO) activity
Homogenates were centrifuged at 15,000 x g for 10 min at 4°C. A 100 mL-aliquot of supernatant was mixed with 900 mL of 50 mmol·L ·cm -1 at 460 nm 29 .
Cytokine assay
Tissue TNF-α content was measured in lung homogenates using commercially available, rat-specific enzyme immunoassay (ELISA) kits (Quantikine, R&D Systems, MN, USA). Results were expressed as pg/mL. Absorbance was determined at 450 nm using a microplate reader (Bio-Tek Instruments, VT, USA).
Morphology
The middle lobe of the right lung was fixed in buffered formalin. After embedding in paraffin, 4-μm sections of the tissues were stained with hematoxylin-eosin (HE) for light microscopy coupled to a video camera (Axiolab Standart 2.0 and AxionCam, Zeiss, Jena, Germany, respectively). The slides were evaluated blindly by an independent consultant histopathologist.
Wet to dry tissue weight ratio
The lower lobe of the right lung was isolated and immediately weighed (wet weight) before being dried for 48 h at 80°C and weighed again (dry weight). The wet/dry weight ratio was then calculated.
Statistical analysis
Statistical analyses were carried out with a SPSS 11.0 statistical software (SPSS Inc. Software, IL, USA). Data were analyzed by 1-way analysis of variance (ANOVA) with a LSD post-hoc test to determine comparisons and differences between groups, respectively. All values are expressed as mean ± standard deviation with P<0.05 being considered significant.
Results
No deaths were recorded throughout the experiment. The protein content in BALs (Figure 1 ) increased in the group SS+IR (62.71 ± 4.61 mg/mL), and decreased in the groups treated with PTX (I+PTX+R: 50.14 ± 3.93 mg/mL; PTX+I+PTX+R: 36.28 ± Myeloperoxidase activity (MPO; Figure 3) The levels of TNF-alpha ( Figure 4 ) in lung homogenates were higher in all groups when compared with those of the Sham group. The has been an increase of TNF-alpha levels in the group SS+IR (67.14 ± 6.82 ρg/mL), and a reduction in PTX-treated groups, I+PTX+R (55.86 ± 2.27 pg/mL) and PTX+I+PTX+R (47.57 ± 2.64 pg/mL). 
mg/mL).
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Discussion
Our current study showed that I/R caused acute lung Intestinal I/R injury causes local damage as well as remote organ injury and dysfunction. The pathophysiology of I/R injury is complex, the induction of a systemic proinflammatory cytokine response is believed to play a major role, and TNF-alpha is among the most important contributors 34, 35 . In a elegant study conducted by Cámara-Lemarroy et al.
36
, showed that intestinal I/R-induced lung injury was associated with elevated levels of circulating serum TNF-alpha, and the treatment of one dose of PTX reduced the intensity of injury and the tissue edema. Lung cytokine levels are actually determined by the amount of cytokines released from a variety of cell populations, including alveolar macrophages, endothelial cells, and epithelial cells, and these multiple sources mean that reduced neutrophil infiltration of the lungs may not directly translate to a decreased level of cytokines in the lung [37] [38] [39] .
Our studies corroborated with these authors and expanded of the result. In our study, the TNF-alpha levels in homogenate lung tissue were higher in the saline-treated group (SS+IR) and reduced in the group I+PTX+R, but the decreased was more significant in the group treated with three doses of pentoxifylline (PTX+I+PTX+R).
Morphological examination indicate the severe impact in the lung tissue submitted to I/R non-treated, by other hand the treatment with PTX reduced the lung damage, especially in the group treated with three doses of PTX.
Our study demonstrated that pentoxifylline had preventive effects and therapeutic potential in I/R-induced lung injury, but our results must be considered carefully. The clinical relevance of this manuscript refers to the previous use of pentoxifylline in situations requiring procedures ischemia with reperfusion to reduce or prevent distant organs damage. Therefore, the long-term effect of pentoxifylline warrants further investigation.
In conclusion, our study showed that pentoxifylline decreased lung edema, ameliorated lung histological change, reduced the production of inflammatory mediators, and neutrophils in intestinal I/R-induced lung injury. Pentoxifylline has been given
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safely in previous clinical studies. Therefore, the administration of pentoxifylline may be a useful prophylactic or adjunct drug therapy for intestinal I/R-induced lung injury.
